CDC: 60 Percent of America's Single Men Report Using Condoms

Share this content:
CDC: 60 Percent of America's Single Men Report Using Condoms
CDC: 60 Percent of America's Single Men Report Using Condoms

THURSDAY, Aug. 31, 2017 (HealthDay News) -- About six in 10 sexually active single men in the United States are taking responsibility for birth control, according to an August data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.

The researchers analyzed data collected between 2011 and 2015 for the National Survey of Family Growth. They found that use of any male birth control method by unmarried men who had sexual intercourse in the last three months rose from 52.2 percent in 2002 to 59.3 percent by 2011 to 2015. When the researchers looked at male and female contraception combined, they found that 81.7 percent of men who'd had sex in the past 90 days said either they or their partner had used some type of birth control.

Condom use varied by marital status, age, and race, the investigators found. Six out of 10 never-married men (60.8 percent) reported using condoms, followed by 35.2 percent of formerly married men and about one-quarter (23.5 percent) of cohabitating men. Racially, more than half of single black men (54.3 percent) used a condom compared to 44.2 percent of their white peers and 42.1 percent of Hispanics. In terms of age, more than three-quarters (75.5 percent) of 15- to 19-year-old men used condoms compared to just over one-quarter (25.8 percent) of men aged 35 to 44.

The proportion of men relying on condoms or vasectomy hasn't changed since 2002, but use of withdrawal before ejaculation has, according to the report, with rates rising from 9.8 percent in 2002 to 18.8 percent in 2011 to 2015.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »